Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
Karina Huynh(Baker Heart and Diabetes Institute), Rebecca H. Ritchie(Baker Heart and Diabetes Institute)
Cited by 145
Related Papers
Basic Mechanisms of Diabetic Heart Disease
|Circulation Research|2020|690
Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes
|Diabetologia|2012|164
Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes
|Diabetologia|2012|89
The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
|PLoS ONE|2012|62
Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes
|Frontiers in Physiology|2020|50